URELLE (hyoscyamine sulfate, methenamine, methylene blue, phenyl salicylate, sodium phosphate) tablets – label (2025)

Government Record · Viatris Specialty LLC; U.S. National Library of Medicine DailyMed · August 25, 2025

Viatris Specialty LLC et al., 2025-08-25: Label of a marketed human urinary-antiseptic combination product: 10.8 mg methylene blue per tablet, indicated for symptoms of irritative voiding rather than for bacterial cure.

Each Tablet Contains: Hyoscyamine Sulfate 0.12 mg Methenamine 81.0 mg Methylene Blue 10.8 mg Phenyl Salicylate 32.4 mg Sodium Phosphate Monobasic 40.8 mg

1

Viatris Specialty LLC et al., 2025-08-25: Label of a marketed human urinary-antiseptic combination product: 10.8 mg methylene blue per tablet, indicated for symptoms of irritative voiding rather than for bacterial cure. C8. Label field transcription (record field, DESCRIPTION block, PDF page 1). Indications as stated: for the treatment of symptoms of irritative voiding, for relief of local symptoms accompanying lower urinary tract infections, and for urinary tract symptoms caused by diagnostic procedures. No antibacterial cure claim in the indication. Label holder Viatris Specialty LLC; SPL published 2025-08-25. Methylene blue content 10.8 mg per tablet, recorded in full as the claim requires. Study type: regulatory record.